Neeraj Agarwal

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (181)

• Impact of Prior Treatments on Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer: A Real-World Analysis in the United States
  Clinical Genitourinary Cancer 2026 DOI: 10.1016/j.clgc.2026.102574
  +Save
• Concurrent tissue and circulating tumor DNA analysis in renal cell carcinoma: insights from a multimodal database
  The Oncologist 2026 DOI: 10.1093/oncolo/oyag123
  +Save
• Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy
  The Oncologist 2026 DOI: 10.1093/oncolo/oyag100
  +Save
• Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
  Nature Communications 2025 DOI: 10.1038/s41467-025-67298-z
  +Save
• Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial
  Nature Medicine 2025 DOI: 10.1038/s41591-025-03961-8
  +Save
• Data from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer
  2025 DOI: 10.1158/1078-0432.c.6861315
  +Save
• Supplementary Data 1 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer
  2025 DOI: 10.1158/1078-0432.30708933
  +Save
• Supplementary Figure 1 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer
  2025 DOI: 10.1158/1078-0432.30708930
  +Save
• Supplementary table 1 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer
  2025 DOI: 10.1158/1078-0432.30708927
  +Save
• Supplementary table 2 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer
  2025 DOI: 10.1158/1078-0432.30708924
  +Save